CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Endocrinology Pediatrics Oncology
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
Oncology Pediatrics Endocrinology
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Interactive e-learning
Oncology Pediatrics
TRK fusion-positive sarcomas and lung cancer e-learning
Experts
Prof. Erin Rudzinski, Prof. Robin Jones, Prof. Christian Rolfo-
Downloadable
Resouces -
60 MIN
-
Sep 2021
Oncology
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Oncology Rare diseases Pediatrics
Targeting NTRK gene fusions
Experts
Prof. Fernando López-Ríos, Prof. Andrea Sartore-Bianchi, Assoc. Prof. Gerald Prager, Dr Jaclyn Hechtman-
30 MIN
-
Dec 2021
Podcast
Oncology Pediatrics
Podcast: TRK fusion-positive lung cancer
Experts
Prof. Christian Rolfo, Assoc. Prof. Caterina Marchiò-
Downloadable
Resouces -
20 MIN
-
Dec 2021
Rare diseases Oncology
TRK fusion-positive cancer highlights from ASCO 2022
Experts
Prof. David Hong-
Downloadable
Resouces -
5 MIN
-
Jun 2022
Interactive e-learning
Module
1
of 3
Oncology
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer
Assoc. Prof. Caterina Marchio: A lung cancer case
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
Downloadable
Resouces -
15 MIN
-
Aug 2022
TRK fusion-positive cancer: new ESMO OncologyPRO learning resource
Experts
Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca, Prof. Silvia Stacchiotti, Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Prof. Christian Rolfo-
30 MIN
-
Aug 2022
Oncology
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Oncology
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
-
Downloadable
Resouces -
5 MIN
-
Sep 2022
Episode
1
of 3
Oncology
TRK fusion-positive cancer poster tour at ESMO 2022
Poster 1: Dufresne A. et al (ESMO 2022)
Experts
Prof. David Hong-
1 MIN
-
Oct 2022
Video
Episode
1
of 2
Oncology
The Role of the Nurse in nmCRPC Patient Management
The role of the nurse in nmCRPC patient management
Experts
Pablo PeinadoEndorsed by
-
Downloadable
Resouces -
5 MIN
-
Mar 2023
Interactive patient case
Oncology
Diagnosis and Treatment of TRK Fusion-Positive Lung Cancer
How will your clinical decisions impact a patient at two key stages in their journey?
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
May 2023
Conference update
Episode
1
of 6
Oncology Obstetrics and Gynecology Hemato-oncology
Listen to Expert Insights on Late-Breaking Data from ASCO 2023
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Experts
Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager-
2 MIN
-
Jun 2023
Video
Oncology Pediatrics
Conference Update: ASCO and WCGIC 2023
An expert perspective on the latest data in precision oncology
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Jul 2023
Conference update
Oncology
Lung cancer highlights from ESMO 2023
An expert panel discussion hosted by eChinaHealth and COR2ED
-
43 MIN
-
Oct 2023